Pregled bibliografske jedinice broj: 1088538
Long-lasting control of triple-negative metastatic breast cancer with the novel drug combination ixabepilone and capecitabine - case report
Long-lasting control of triple-negative metastatic breast cancer with the novel drug combination ixabepilone and capecitabine - case report // Onkologie, 33 (2010), 53-56 doi:10.1159/0002646615 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1088538 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Long-lasting control of triple-negative metastatic
breast cancer with the novel drug combination
ixabepilone and capecitabine - case report
Autori
Vrdoljak Eduard, Branka Petrić Miše, Blanka Lukić, Zvonimir Curić, Lidija Bošković
Izvornik
Onkologie (0378-584X) 33
(2010);
53-56
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Metastatic breast cancer, taxane, ixabepilone, peripheral neuropathy
Sažetak
Summary Background: The optimal duration of ixabepilone andcapecitabine chemotherapy combination is currently not known and will most likely be patient-specific based on efficacy, toxicity, quality of life, and patient preference. Case Report: We report an extremely long duration ofchemotherapy with ixabepilone and capecitabine (42 cycles)in a patient with triple-negative metastatic breast cancer previously treated with anthracyclines and taxanes.Partial remission was achieved, and acceptable toxicity was observed. Conclusions: This report adds to the pool of knowledge regarding the use of this important new metastatic breast cancer regimen, especially with respect to the optimal duration of its use.
Izvorni jezik
Ger
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
